Josephine Sollano | Head, Global Health Economics and Outcomes
Pfizer

Dr. Josephine Sollano is a Global Leader in Health Economics and Outcomes Research and Medical Communications Teams for Pfizer, Inc. within the Oncology Business Unit based in New York City. In her current role, Jo is responsible for the strategic development of economic and humanistic evidence required by payors, patients, and prescribers as well as the oversight for internal and external scientific communication across the oncology portfolio. Prior to entering the pharmaceutical industry, Jo held several academic leadership roles including a senior policy and research position within InCHOIR at Columbia University, Executive Director of the Institute for Clinical Excellence at the NewYork-Presbyterian Medical Center, and Associate Vice President of Quality Management and Outcomes at the Northshore Long Island Jewish Healthcare System. Jo began her career in industry at Sanofi and later joined GlaxoSmithKline where she led a team responsible for Market Access and Health Economics & Outcomes in cardiovascular and metabolic diseases. Jo holds a Doctoral degree in International Health Policy and Health Economics as well as a Master’s degree in Cardiovascular Epidemiology from Columbia University School of Public Health. Dr. Sollano has published papers, abstracts, and book chapters as well as lectured extensively on market access, health economics, and personalized medicine.